MANUEL
PRAGA TERENTE
Profesor emérito
Fundación Jiménez Díaz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (28)
2023
-
Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy
Kidney360, Vol. 4, Núm. 5, pp. 659-672
-
Consensus document of the Spanish Group for the Study of the Glomerular Diseases (GLOSEN) for the diagnosis and treatment of lupus nephritis
Nefrologia, Vol. 43, Núm. 1, pp. 6-47
2022
-
Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy
Clinical Kidney Journal, Vol. 15, Núm. 9, pp. 1737-1746
-
Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy
Journal of the American Society of Nephrology : JASN, Vol. 33, Núm. 6, pp. 1137-1153
-
Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 7, pp. 1270-1280
2021
-
Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy
Journal of the American Society of Nephrology, Vol. 32, Núm. 2
-
The Role of Vascular Lesions in Diabetes Across a Spectrum of Clinical Kidney Disease
Kidney International Reports, Vol. 6, Núm. 9, pp. 2392-2403
-
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy
Kidney International, Vol. 99, Núm. 4, pp. 986-998
-
The authors reply
Kidney International
-
The authors reply
Kidney International
-
Validation of a Histologic Scoring Index for C3 Glomerulopathy
American Journal of Kidney Diseases, Vol. 77, Núm. 5, pp. 684-695.e1
2020
-
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 35, Núm. 6, pp. 1002-1009
-
Mycophenolate mofetil in c3 glomerulopathy and pathogenic drivers of the disease
Clinical Journal of the American Society of Nephrology, Vol. 15, Núm. 9, pp. 1287-1298
-
Risk factors for non-diabetic renal disease in diabetic patients
Clinical Kidney Journal, Vol. 13, Núm. 3, pp. 380-388
2019
-
Glomerular hematuria: Cause or consequence of renal inflammation?
International Journal of Molecular Sciences, Vol. 20, Núm. 9
-
Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome
Kidney International, Vol. 96, Núm. 4, pp. 995-1004
2017
-
Eculizumab in secondary atypical haemolytic uraemic syndrome
Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 466-474
2015
-
Effectiveness of mycophenolate mofetil in C3 glomerulonephritis
Kidney International, Vol. 88, Núm. 5, pp. 1153-1160
-
Malignant hypertension: A type of IgA nephropathy manifestation with poor prognosis
Nefrologia, Vol. 35, Núm. 1, pp. 42-49